Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

Update Il y a 4 ans
Reference: NCT01086878

Woman and Man

  • | Country :
  • Botswana
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine if prophylactic cotrimoxazole makes severe anemia or neutropenia more common in infants exposed to maternal HIV and combination antiretroviral therapy.


Inclusion criteria

  • Acquired Immunodeficiency Syndrome ,Infant, Newborn ,Anemia ,Neutropenia ,HIV Infections

Links